- Targeting dysregulated lipid metabolism in the tumor microenvironment
Do-Hee Kim et al, 2023, Archives of Pharmacal Research CrossRef - Diastereoisomer separation of silybin A and silybin B by semi‐preparative liquid chromatography using Box–Behnken design
Hong Liu et al, 2023, SEPARATION SCIENCE PLUS CrossRef - Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS
Xinyi Wei et al, 2024, Frontiers in Pharmacology CrossRef - Silibinin ameliorates deoxycholic acid-induced pyroptosis in steatotic HepG2 cells by inhibiting NLRP3 inflammasome activation
Meiqing Mai et al, 2023, Biochemistry and Biophysics Reports CrossRef - Highly Accessible Computational Prediction and In Vivo/In Vitro Experimental Validation: Novel Synthetic Phenyl Ketone Derivatives as Promising Agents against NAFLD via Modulating Oxidoreductase Activity
Yanan Qiao et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef - Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review
Pervej Alom Barbhuiya et al, 2023, Phytochemistry Reviews CrossRef - In Vitro Influence of Specific Bacteroidales Strains on Gut and Liver Health Related to Metabolic Dysfunction-Associated Fatty Liver Disease
Diego Garcia-Morena et al, 2024, Probiotics and Antimicrobial Proteins CrossRef - Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD
Han Zhang et al, 2021, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef - Silibinin protects GLUTag cells from PA-induced injury via suppressing endoplasmic reticulum stress
Xinyi Shi et al, 2023, CyTA - Journal of Food CrossRef - An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database
Bo Zhang et al, 2023, British Journal of Clinical Pharmacology CrossRef